Find verified Pemetrexed dipotassium heptahydrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Pemetrexed dipotassium heptahydrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Pemetrexed dipotassium heptahydrate API.
Alternate Names: Axtle (TN), L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, potassium salt, hydrate (1:2:7)
CAS No: 2668267-29-4
PubChem CID: 136238656
Mol Formula: C20H33K2N5O13
Mol Weight: 629.7 g/mol
IUPAC Name: dipotassium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate;heptahydrate
API Description: Pemetrexed dipotassium heptahydrate is a chemotherapy drug used primarily to treat malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). It works as a folate analog metabolic inhibitor, disrupting folate-dependent processes essential for cell replication by inhibiting enzymes involved in the biosynthesis of thymidine and purine nucleotides.
